Chapter 1. Research Scope & Methodology
1.1 Market Definition
1.2 Analysis Period & Currency
1.3 Segmentation
1.4 Artificial Intelligence In Precision Medicine Market, by Geography
1.5 Research Methodology
Chapter 2. Market Overview
2.1 COVID-19 Impact
2.2 Market Composition and Scenario
Chapter 3. Key Factors Impacting Market
3.1 Market Drivers
3.2 Market Restraints
3.3 Market Opportunities
3.4 Market Challenges
3.5 Market Trends
3.6 State of Competition
3.7 Market Consolidation
3.8 Key Customer Criteria
Chapter 4. Product Life Cycle
Chapter 5. Value Chain Analysis of Artificial Intelligence in Precision Medicine Market
Chapter 6. Competition Analysis - Global
6.1 Market Share Analysis
6.2 Recent Developments
6.2.1 Mergers & Acquisitions
6.2.2 Product Launch & Product Expansion
6.2.3 Partnership, Collaboration & Agreements
6.2.4 Geographical Expansion
Chapter 7. Segmentation By Component
7.1 Software
7.2 Services
7.3 Hardware
Chapter 8. Segmentation By Technology
8.1 Deep Learning
8.2 Natural Language Processing
8.3 Querying Method
8.4 Context Aware Processing
Chapter 9. Segmentation By Therapeutic Application
9.1 Oncology
9.2 Cardiology
9.3 Neurology
9.4 Respiratory
9.5 Other Therapeutic Applications
Chapter 10. North America Market
10.1 Market Overview
10.2 Key Factors Impacting Market
10.2.1 Market Drivers
10.2.2 Market Restraints
10.2.3 Market Opportunities
10.2.4 Market Challenges
10.2.5 Market Trends
10.2.6 State of Competition
10.2.7 Market Consolidation
10.2.8 Key Customer Criteria
10.3 Product Life Cycle
10.4 Segmentation By Component
10.4.1 Software
10.4.2 Services
10.4.3 Hardware
10.5 Segmentation By Technology
10.5.1 Deep Learning
10.5.2 Natural Language Processing
10.5.3 Querying Method
10.5.4 Context-Aware Processing
10.6 Segmentation By Therapeutic Application
10.6.1 Oncology
10.6.2 Cardiology
10.6.3 Neurology
10.6.4 Respiratory
10.6.5 Other Therapeutic Application
10.7 Segmentation By Country
10.7.1 US
10.7.1.1 Segmentation By Component
10.7.1.1.1 Software
10.7.1.1.2 Services
10.7.1.1.3 Hardware
10.7.1.2 Segmentation By Technology
10.7.1.2.1 Deep Learning
10.7.1.2.2 Natural Language Processing
10.7.1.2.3 Querying Method
10.7.1.2.4 Context Aware Processing
10.7.1.3 Segmentation By Therapeutic Application
10.7.1.3.1 Oncology
10.7.1.3.2 Cardiology
10.7.1.3.3 Neurology
10.7.1.3.4 Respiratory
10.7.1.3.5 Other Therapeutic Application
10.7.2 Canada
10.7.2.1 Segmentation By Component
10.7.2.1.1 Software
10.7.2.1.2 Services
10.7.2.1.3 Hardware
10.7.2.2 Segmentation By Technology
10.7.2.2.1 Deep Learning
10.7.2.2.2 Natural Language Processing
10.7.2.2.3 Querying Method
10.7.2.2.4 Context Aware Processing
10.7.2.3 Segmentation By Therapeutic Application
10.7.2.3.1 Oncology
10.7.2.3.2 Cardiology
10.7.2.3.3 Neurology
10.7.2.3.4 Respiratory
10.7.2.3.5 Other Therapeutic Application
10.7.3 Mexico
10.7.3.1 Segmentation By Component
10.7.3.1.1 Software
10.7.3.1.2 Services
10.7.3.1.3 Hardware
10.7.3.2 Segmentation By Technology
10.7.3.2.1 Deep Learning
10.7.3.2.2 Natural Language Processing
10.7.3.2.3 Querying Method
10.7.3.2.4 Context Aware Processing
10.7.3.3 Segmentation By Therapeutic Application
10.7.3.3.1 Oncology
10.7.3.3.2 Cardiology
10.7.3.3.3 Neurology
10.7.3.3.4 Respiratory
10.7.3.3.5 Other Therapeutic Application
10.7.4 Rest of North America
10.7.4.1 Segmentation By Component
10.7.4.1.1 Software
10.7.4.1.2 Services
10.7.4.1.3 Hardware
10.7.4.2 Segmentation By Technology
10.7.4.2.1 Deep Learning
10.7.4.2.2 Natural Language Processing
10.7.4.2.3 Querying Method
10.7.4.2.4 Context Aware Processing
10.7.4.3 Segmentation By Therapeutic Application
10.7.4.3.1 Oncology
10.7.4.3.2 Cardiology
10.7.4.3.3 Neurology
10.7.4.3.4 Respiratory
10.7.4.3.5 Other Therapeutic Application
Chapter 11. Europe Market
11.1 Market Overview
11.2 Key Factors Impacting Market
11.2.1 Market Drivers
11.2.2 Market Restraints
11.2.3 Market Opportunities
11.2.4 Market Challenges
11.2.5 Market Trends
11.2.6 State of Competition
11.2.7 Market Consolidation
11.2.8 Key Customer Criteria
11.3 Product Life Cycle
11.4 Segmentation By Component
11.4.1 Software
11.4.2 Services
11.4.3 Hardware
11.5 Segmentation By Technology
11.5.1 Deep Learning
11.5.2 Natural Language Processing
11.5.3 Querying Method
11.5.4 Context Aware Processing
11.6 Segmentation By Therapeutic Application
11.6.1 Oncology
11.6.2 Cardiology
11.6.3 Neurology
11.6.4 Respiratory
11.6.5 Other Therapeutic Applications
11.7 Segmentation By Country
11.7.1 Germany
11.7.1.1 Segmentation By Component
11.7.1.1.1 Software
11.7.1.1.2 Services
11.7.1.1.3 Hardware
11.7.1.2 Segmentation By Technology
11.7.1.2.1 Deep Learning
11.7.1.2.2 Natural Language Processing
11.7.1.2.3 Querying Method
11.7.1.2.4 Context Aware Processing
11.7.1.3 Segmentation By Therapeutic Application
11.7.1.3.1 Oncology
11.7.1.3.2 Cardiology
11.7.1.3.3 Neurology
11.7.1.3.4 Respiratory
11.7.1.3.5 Other Therapeutic Application
11.7.2 UK
11.7.2.1 Segmentation By Component
11.7.2.1.1 Software
11.7.2.1.2 Services
11.7.2.1.3 Hardware
11.7.2.2 Segmentation By Technology
11.7.2.2.1 Deep Learning
11.7.2.2.2 Natural Language Processing
11.7.2.2.3 Querying Method
11.7.2.2.4 Context Aware Processing
11.7.2.3 Segmentation By Therapeutic Application
11.7.2.3.1 Oncology
11.7.2.3.2 Cardiology
11.7.2.3.3 Neurology
11.7.2.3.4 Respiratory
11.7.2.3.5 Other Therapeutic Application
11.7.3 France
11.7.3.1 Segmentation By Component
11.7.3.1.1 Software
11.7.3.1.2 Services
11.7.3.1.3 Hardware
11.7.3.2 Segmentation By Technology
11.7.3.2.1 Deep Learning
11.7.3.2.2 Natural Language Processing
11.7.3.2.3 Querying Method
11.7.3.2.4 Context Aware Processing
11.7.3.3 Segmentation By Therapeutic Application
11.7.3.3.1 Oncology
11.7.3.3.2 Cardiology
11.7.3.3.3 Neurology
11.7.3.3.4 Respiratory
11.7.3.3.5 Other Therapeutic Application
11.7.4 Russia
11.7.4.1 Segmentation By Component
11.7.4.1.1 Software
11.7.4.1.2 Services
11.7.4.1.3 Hardware
11.7.4.2 Segmentation By Technology
11.7.4.2.1 Deep Learning
11.7.4.2.2 Natural Language Processing
11.7.4.2.3 Querying Method
11.7.4.2.4 Context Aware Processing
11.7.4.3 Segmentation By Therapeutic Application
11.7.4.3.1 Oncology
11.7.4.3.2 Cardiology
11.7.4.3.3 Neurology
11.7.4.3.4 Respiratory
11.7.4.3.5 Other Therapeutic Application
11.7.5 Spain
11.7.5.1 Segmentation By Component
11.7.5.1.1 Software
11.7.5.1.2 Services
11.7.5.1.3 Hardware
11.7.5.2 Segmentation By Technology
11.7.5.2.1 Deep Learning
11.7.5.2.2 Natural Language Processing
11.7.5.2.3 Querying Method
11.7.5.2.4 Context Aware Processing
11.7.5.3 Segmentation By Therapeutic Application
11.7.5.3.1 Oncology
11.7.5.3.2 Cardiology
11.7.5.3.3 Neurology
11.7.5.3.4 Respiratory
11.7.5.3.5 Other Therapeutic Application
11.7.6 Italy
11.7.6.1 Segmentation By Component
11.7.6.1.1 Software
11.7.6.1.2 Services
11.7.6.1.3 Hardware
11.7.6.2 Segmentation By Technology
11.7.6.2.1 Deep Learning
11.7.6.2.2 Natural Language Processing
11.7.6.2.3 Querying Method
11.7.6.2.4 Context Aware Processing
11.7.6.3 Segmentation By Therapeutic Application
11.7.6.3.1 Oncology
11.7.6.3.2 Cardiology
11.7.6.3.3 Neurology
11.7.6.3.4 Respiratory
11.7.6.3.5 Other Therapeutic Application
11.7.7 Rest of Europe
11.7.7.1 Segmentation By Component
11.7.7.1.1 Software
11.7.7.1.2 Services
11.7.7.1.3 Hardware
11.7.7.2 Segmentation By Technology
11.7.7.2.1 Deep Learning
11.7.7.2.2 Natural Language Processing
11.7.7.2.3 Querying Method
11.7.7.2.4 Context Aware Processing
11.7.7.3 Segmentation By Therapeutic Application
11.7.7.3.1 Oncology
11.7.7.3.2 Cardiology
11.7.7.3.3 Neurology
11.7.7.3.4 Respiratory
11.7.7.3.5 Other Therapeutic Application
Chapter 12. Asia Pacific Market
12.1 Market Overview
12.2 Key Factors Impacting Market
12.2.1 Market Drivers
12.2.2 Market Restraints
12.2.3 Market Opportunities
12.2.4 Market Challenges
12.2.5 Market Trends
12.2.6 State of Competition
12.2.7 Market Consolidation
12.2.8 Key Customer Criteria
12.3 Product Life Cycle
12.4 Segmentation By Component
12.4.1 Software
12.4.2 Services
12.4.3 Hardware
12.5 Segmentation By Technology
12.5.1 Deep Learning
12.5.2 Natural Language Processing (NLP)
12.5.3 Querying Method
12.5.4 Context Aware Processing
12.6 Segmentation By Therapeutic Application
12.6.1 Oncology
12.6.2 Cardiology
12.6.3 Neurology
12.6.4 Respiratory
12.6.5 Other Therapeutic Application
12.7 Segmentation By Country
12.7.1 China
12.7.1.1 Segmentation By Component
12.7.1.1.1 Software
12.7.1.1.2 Services
12.7.1.1.3 Hardware
12.7.1.2 Segmentation By Technology
12.7.1.2.1 Deep Learning
12.7.1.2.2 Natural Language Processing
12.7.1.2.3 Querying Method
12.7.1.2.4 Context Aware Processing
12.7.1.3 Segmentation By Therapeutic Application
12.7.1.3.1 Oncology
12.7.1.3.2 Cardiology
12.7.1.3.3 Neurology
12.7.1.3.4 Respiratory
12.7.1.3.5 Other Therapeutic Application
12.7.2 Japan
12.7.2.1 Segmentation By Component
12.7.2.1.1 Software
12.7.2.1.2 Services
12.7.2.1.3 Hardware
12.7.2.2 Segmentation By Technology
12.7.2.2.1 Deep Learning
12.7.2.2.2 Natural Language Processing
12.7.2.2.3 Querying Method
12.7.2.2.4 Context Aware Processing
12.7.2.3 Segmentation By Therapeutic Application
12.7.2.3.1 Oncology
12.7.2.3.2 Cardiology
12.7.2.3.3 Neurology
12.7.2.3.4 Respiratory
12.7.2.3.5 Other Therapeutic Application
12.7.3 India
12.7.3.1 Segmentation By Component
12.7.3.1.1 Software
12.7.3.1.2 Services
12.7.3.1.3 Hardware
12.7.3.2 Segmentation By Technology
12.7.3.2.1 Deep Learning
12.7.3.2.2 Natural Language Processing
12.7.3.2.3 Querying Method
12.7.3.2.4 Context Aware Processing
12.7.3.3 Segmentation By Therapeutic Application
12.7.3.3.1 Oncology
12.7.3.3.2 Cardiology
12.7.3.3.3 Neurology
12.7.3.3.4 Respiratory
12.7.3.3.5 Other Therapeutic Application
12.7.4 South Korea
12.7.4.1 Segmentation By Component
12.7.4.1.1 Software
12.7.4.1.2 Services
12.7.4.1.3 Hardware
12.7.4.2 Segmentation By Technology
12.7.4.2.1 Deep Learning
12.7.4.2.2 Natural Language Processing
12.7.4.2.3 Querying Method
12.7.4.2.4 Context Aware Processing
12.7.4.3 Segmentation By Therapeutic Application
12.7.4.3.1 Oncology
12.7.4.3.2 Cardiology
12.7.4.3.3 Neurology
12.7.4.3.4 Respiratory
12.7.4.3.5 Other Therapeutic Application
12.7.5 Singapore
12.7.5.1 Segmentation By Component
12.7.5.1.1 Software
12.7.5.1.2 Services
12.7.5.1.3 Hardware
12.7.5.2 Segmentation By Technology
12.7.5.2.1 Deep Learning
12.7.5.2.2 Natural Language Processing
12.7.5.2.3 Querying Method
12.7.5.2.4 Context Aware Processing
12.7.5.3 Segmentation By Therapeutic Application
12.7.5.3.1 Oncology
12.7.5.3.2 Cardiology
12.7.5.3.3 Neurology
12.7.5.3.4 Respiratory
12.7.5.3.5 Other Therapeutic Application
12.7.6 Malaysia
12.7.6.1 Segmentation By Component
12.7.6.1.1 Software
12.7.6.1.2 Services
12.7.6.1.3 Hardware
12.7.6.2 Segmentation By Technology
12.7.6.2.1 Deep Learning
12.7.6.2.2 Natural Language Processing
12.7.6.2.3 Querying Method
12.7.6.2.4 Context Aware Processing
12.7.6.3 Segmentation By Therapeutic Application
12.7.6.3.1 Oncology
12.7.6.3.2 Cardiology
12.7.6.3.3 Neurology
12.7.6.3.4 Respiratory
12.7.6.3.5 Other Therapeutic Application
12.7.7 Rest of Asia Pacific
12.7.7.1 Segmentation By Component
12.7.7.1.1 Software
12.7.7.1.2 Services
12.7.7.1.3 Hardware
12.7.7.2 Segmentation By Technology
12.7.7.2.1 Deep Learning
12.7.7.2.2 Natural Language Processing
12.7.7.2.3 Querying Method
12.7.7.2.4 Context Aware Processing
12.7.7.3 Segmentation By Therapeutic Application
12.7.7.3.1 Oncology
12.7.7.3.2 Cardiology
12.7.7.3.3 Neurology
12.7.7.3.4 Respiratory
12.7.7.3.5 Other Therapeutic Application
Chapter 13. LAMEA Market
13.1 Market Overview
13.2 Key Factors Impacting Market
13.2.1 Market Drivers
13.2.2 Market Restraints
13.2.3 Market Opportunities
13.2.4 Market Challenges
13.2.5 Market Trends
13.2.6 State of Competition
13.2.7 Market Consolidation
13.2.8 Key Customer Criteria
13.3 Product Life Cycle
13.4 Segmentation By Component
13.4.1 Software
13.4.2 Services
13.4.3 Hardware
13.5 Segmentation By Technology
13.5.1 Deep Learning
13.5.2 Natural Language Processing
13.5.3 Querying Method
13.5.4 Context Aware Processing
13.6 Segmentation By Therapeutic Application
13.6.1 Oncology
13.6.2 Cardiology
13.6.3 Neurology
13.6.4 Respiratory
13.6.5 Other Therapeutic Application
13.7 Segmentation By Country
13.7.1 Brazil
13.7.1.1 Segmentation By Component
13.7.1.1.1 Software
13.7.1.1.2 Services
13.7.1.1.3 Hardware
13.7.1.2 Segmentation By Technology
13.7.1.2.1 Deep Learning
13.7.1.2.2 Natural Language Processing
13.7.1.2.3 Querying Method
13.7.1.2.4 Context Aware Processing
13.7.1.3 Segmentation By Therapeutic Application
13.7.1.3.1 Oncology
13.7.1.3.2 Cardiology
13.7.1.3.3 Neurology
13.7.1.3.4 Respiratory
13.7.1.3.5 Other Therapeutic Application
13.7.2 Argentina
13.7.2.1 Segmentation By Component
13.7.2.1.1 Software
13.7.2.1.2 Services
13.7.2.1.3 Hardware
13.7.2.2 Segmentation By Technology
13.7.2.2.1 Deep Learning
13.7.2.2.2 Natural Language Processing
13.7.2.2.3 Querying Method
13.7.2.2.4 Context Aware Processing
13.7.2.3 Segmentation By Therapeutic Application
13.7.2.3.1 Oncology
13.7.2.3.2 Cardiology
13.7.2.3.3 Neurology
13.7.2.3.4 Respiratory
13.7.2.3.5 Other Therapeutic Application
13.7.3 UAE
13.7.3.1 Segmentation By Component
13.7.3.1.1 Software
13.7.3.1.2 Services 13.7.3.1.3 Hardware
13.7.3.2 Segmentation By Technology
13.7.3.2.1 Deep Learning
13.7.3.2.2 Natural Language Processing
13.7.3.2.3 Querying Method
13.7.3.2.4 Context Aware Processing
13.7.3.3 Segmentation By Therapeutic Application
13.7.3.3.1 Oncology
13.7.3.3.2 Cardiology
13.7.3.3.3 Neurology
13.7.3.3.4 Respiratory
13.7.3.3.5 Other Therapeutic Application
13.7.4 Saudi Arabia
13.7.4.1 Segmentation By Component
13.7.4.1.1 Software
13.7.4.1.2 Services
13.7.4.1.3 Hardware
13.7.4.2 Segmentation By Technology
13.7.4.2.1 Deep Learning
13.7.4.2.2 Natural Language Processing
13.7.4.2.3 Querying Method
13.7.4.2.4 Context Aware Processing
13.7.4.3 Segmentation By Therapeutic Application
13.7.4.3.1 Oncology
13.7.4.3.2 Cardiology
13.7.4.3.3 Neurology
13.7.4.3.4 Respiratory
13.7.4.3.5 Other Therapeutic Application
13.7.5 South Africa
13.7.5.1 Segmentation By Component
13.7.5.1.1 Software
13.7.5.1.2 Services
13.7.5.1.3 Hardware
13.7.5.2 Segmentation By Technology
13.7.5.2.1 Deep Learning
13.7.5.2.2 Natural Language Processing
13.7.5.2.3 Querying Method
13.7.5.2.4 Context Aware Processing
13.7.5.3 Segmentation By Therapeutic Application
13.7.5.3.1 Oncology
13.7.5.3.2 Cardiology
13.7.5.3.3 Neurology
13.7.5.3.4 Respiratory
13.7.5.3.5 Other Therapeutic Application
13.7.6 Nigeria
13.7.6.1 Segmentation By Component
13.7.6.1.1 Software
13.7.6.1.2 Services
13.7.6.1.3 Hardware
13.7.6.2 Segmentation By Technology
13.7.6.2.1 Deep Learning
13.7.6.2.2 Natural Language Processing
13.7.6.2.3 Querying Method
13.7.6.2.4 Context Aware Processing
13.7.6.3 Segmentation By Therapeutic Application
13.7.6.3.1 Oncology
13.7.6.3.2 Cardiology
13.7.6.3.3 Neurology
13.7.6.3.4 Respiratory
13.7.6.3.5 Other Therapeutic Application
13.7.7 Rest of LAMEA
13.7.7.1 Segmentation By Component
13.7.7.1.1 Software
13.7.7.1.2 Services
13.7.7.1.3 Hardware
13.7.7.2 Segmentation By Technology
13.7.7.2.1 Deep Learning
13.7.7.2.2 Natural Language Processing
13.7.7.2.3 Querying Method
13.7.7.2.4 Context Aware Processing
13.7.7.3 Segmentation By Therapeutic Application
13.7.7.3.1 Oncology
13.7.7.3.2 Cardiology
13.7.7.3.3 Neurology
13.7.7.3.4 Respiratory
13.7.7.3.5 Other Therapeutic Application
Chapter 14. Company Snapshots
14.1 Roche
14.1.1 Business Overview
14.1.2 Key Information
14.1.3 Company Focus on Artificial Intelligence in Precision Medicine Market
14.1.4 Strategic Insights
14.1.5 Strategy Deployed
14.1.6 Product & Service Portfolio
14.1.7 SWOT Analysis
14.1.8 Key Differentiators
14.2 ConcertAI
14.2.1 Business Overview
14.2.2 Key Information
14.2.3 Company Focus on Artificial Intelligence in Precision Medicine Market
14.2.4 Strategic Insights
14.2.5 Portfolio Matrix
14.2.6 SWOT Analysis
14.2.7 Key Differentiators
14.3 SOPHiA GENETICS
14.3.1 Business Overview
14.3.2 Key Information
14.3.3 Company Focus on AI in Precision Medicine
14.3.4 Strategic Insights
14.3.5 Portfolio Matrix
14.3.6 SWOT Analysis
14.3.7 Key Differentiators
14.4 PathAI
14.4.1 Business Overview
14.4.2 Key Information
14.4.3 Company Focus on AI in Precision Medicine
14.4.4 Strategic Insights
14.4.5 Portfolio Matrix
14.4.6 SWOT Analysis
14.4.7 Key Differentiators
14.5 Owkin
14.5.1 Business Overview
14.5.2 Key Information
14.5.3 Company Focus on AI in Precision Medicine
14.5.4 Strategic Insights
14.5.5 Portfolio Matrix
14.5.6 SWOT Analysis
14.5.7 Key Differentiators
14.6 Recursion
14.6.1 Business Overview
14.6.2 Key Information
14.6.3 Company Focus on AI in Precision Medicine
14.6.4 Strategic Insights
14.6.5 Portfolio Matrix
14.6.6 SWOT Analysis
14.6.7 Key Differentiators
14.7 Personalis
14.7.1 Business Overview
14.7.2 Key Information
14.7.3 Company Focus on AI in Precision Medicine
14.7.4 Strategic Insights
14.7.5 Strategy Deployed
14.7.6 Portfolio Matrix
14.7.7 SWOT Analysis
14.7.8 Key Differentiators
14.8 Tempus AI
14.8.1 Business Overview
14.8.2 Key Information
14.8.3 Company Focus on Artificial Intelligence in Precision Medicine Market
14.8.4 Strategic Insights
14.8.5 Strategy Deployed
14.8.6 Product & Service Portfolio
14.8.7 Technology & Innovation Focus
14.8.8 SWOT Analysis
14.8.9 Key Differentiators
14.8.10 Portfolio Matrix
14.8.11 Future Outlook
14.9 Caris Life Sciences
14.9.1 Business Overview
14.9.2 Key Information
14.9.3 Company Focus on Artificial Intelligence in Precision Medicine Market
14.9.4 Strategic Insights
14.9.5 Strategy Deployed
14.9.6 Product & Service Portfolio
14.9.7 Technology & Innovation Focus
14.9.8 SWOT Analysis
14.9.9 Key Differentiators
14.9.10 Portfolio Matrix
14.9.11 Future Outlook
14.10 Guardant Health
14.10.1 Business Overview
14.10.2 Key Information
14.10.3 Company Focus on Artificial Intelligence in Precision Medicine Market
14.10.4 Strategic Insights
14.10.5 Strategy Deployed
14.10.6 Product & Service Portfolio
14.10.7 Technology & Innovation Focus
14.10.8 SWOT Analysis
14.10.9 Key Differentiators
14.10.10 Portfolio Matrix
14.10.11 Future Outlook
14.10.12 Analyst View
Chapter 15. Winning Imperatives of Artificial Intelligence In Precision Medicine Market
Unique Offerings 
